Oracle Fin.Serv. (OFSS)

FairStock Score: 85/100 — HIGH CONVICTION

Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 1/1

Key Financials

Strengths

• Zero debt with ROE of 29.20% and ROCE of 40.60% shows high capital efficiency.
• Piotroski score of 8/9 and Altman Z-score of 6.18 indicate strong financial health and low distress risk.
• High promoter holding of 72.46% aligns ownership with minority shareholders.
• Latest quarter net profit margin is roughly 31% (₹610 Cr profit on ₹1,966 Cr sales), reflecting pricing power.
• Dividend yield of 3.82% provides some income while waiting for capital appreciation.

Concerns

• Growth is weak: sales growth 4.43%, profit growth -6.19%, and 5-year revenue CAGR only 6.56%.
• Valuation is expensive: P/E 24.71, P/B 9.15, and PEG 10.36 leave no margin of safety.
• Free cash flow is negative at -₹173 Cr despite reported profits, raising earnings-quality concerns.
• Price is 180.68% above the Graham Number of ₹2,469.73, meaning the downside protection is absent.

AI Analysis

At first glance, Oracle Financial Services appears to be exactly the kind of company I like to study: a software product business with an impressive moat, minimal financial risk, and a promoter deeply aligned with shareholders. The numbers show no debt, ROE of 29.20%, ROCE of 40.60%, an Altman Z-score of 6.18, and a Piotroski score of 8/9. That is financial strength. Add a 3.82% dividend yield and 72.46% promoter holding, and the business has the texture of a steady compounder. Yet price determines return. At ₹8,791.50, the market is asking me to pay 24.71 times earnings and 9.15 times book value. Graham would tell me to use the Graham Number as a conservative anchor: ₹2,469.73. The current price is nearly 180% above that anchor, so there is no margin of safety. Worse, growth does not support the multiple. Sales rose only 4.43%, profit fell 6.19%, and five-year revenue CAGR is just 6.56%. With a PEG of 10.36, I am paying an extraordinary premium for weak growth. Free cash flow of -₹173 Cr also bothers me; accounting profits are not being converted into cash. This is not an appeal against the business—it is a strong Slow Grower. But my discipline is simple: a wonderful business can still be a poor investment if bought at the wrong price. I would place OFSS on my watchlist and wait for a price that offers margin of safety, maybe closer to my Graham anchor, while monitoring whether growth and cash conversion improve. Patience, not excitement, is the investor's best friend.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer